C. Vlachopoulos

2.1k total citations · 1 hit paper
23 papers, 1.4k citations indexed

About

C. Vlachopoulos is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C. Vlachopoulos has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C. Vlachopoulos's work include Lipoproteins and Cardiovascular Health (4 papers), Cardiovascular Health and Disease Prevention (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). C. Vlachopoulos is often cited by papers focused on Lipoproteins and Cardiovascular Health (4 papers), Cardiovascular Health and Disease Prevention (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). C. Vlachopoulos collaborates with scholars based in Greece, United Kingdom and United States. C. Vlachopoulos's co-authors include D. Duprez, G.E. Plante, Jan A. Staessen, M. F. O'Rourke, Petros Nihoyannopoulos, Arturo Evangelista, Guido Rocchi, Ole A. Breithardt, Juan Zamorano and Mauro Pepi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

C. Vlachopoulos

20 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical applications of arterial stiffness; definitions and reference values

2002 854 citations M. F. O'Rourke, Jan A. Staessen et al. American Journal of Hypertension profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Vlachopoulos Greece	8	1.1k	532	234	176	132	23	1.4k
Erich Kvas Austria	11	1.3k 1.2×	344 0.6×	316 1.4×	231 1.3×	73 0.6×	19	1.7k
Yoichi Inaba United States	10	967 0.9×	387 0.7×	192 0.8×	249 1.4×	96 0.7×	13	1.4k
Gian Paolo Bezante Italy	21	748 0.7×	266 0.5×	260 1.1×	260 1.5×	201 1.5×	59	1.4k
Stéphane Laurent France	9	1.7k 1.6×	510 1.0×	249 1.1×	200 1.1×	83 0.6×	22	2.0k
Παναγιώτα Γεωργιάδου Greece	19	673 0.6×	303 0.6×	207 0.9×	115 0.7×	123 0.9×	53	1.2k
M Huelsmann Austria	18	1.2k 1.1×	278 0.5×	265 1.1×	53 0.3×	193 1.5×	48	1.4k
A Tropeano France	4	1.3k 1.2×	360 0.7×	176 0.8×	166 0.9×	59 0.4×	7	1.5k
Suzanne Holewijn Netherlands	25	610 0.6×	578 1.1×	817 3.5×	117 0.7×	112 0.8×	80	1.6k
Hasan Turhan Türkiye	25	1.1k 1.0×	340 0.6×	556 2.4×	316 1.8×	183 1.4×	85	1.7k
Christoph D. Gatzka Australia	20	1.5k 1.4×	272 0.5×	293 1.3×	149 0.8×	57 0.4×	32	1.9k

Countries citing papers authored by C. Vlachopoulos

Since Specialization

Citations

This map shows the geographic impact of C. Vlachopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Vlachopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Vlachopoulos more than expected).

Fields of papers citing papers by C. Vlachopoulos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Vlachopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Vlachopoulos. The network helps show where C. Vlachopoulos may publish in the future.

Co-authorship network of co-authors of C. Vlachopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of C. Vlachopoulos. A scholar is included among the top collaborators of C. Vlachopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Vlachopoulos. C. Vlachopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rallidis, Lοukianos S., et al.. (2023). Almost 1 in 2 patients with acute coronary syndrome are extremely high-risk and potential candidates for in-hospital triple lipid-lowering therapy: data from the CALLINICUS-Hellas Registry. European Heart Journal. 44(Supplement_2).

Argyris, Antonis, et al.. (2022). Association of gut microbiota composition and their metabolites with subclinical atheromatosis: A systematic review. SHILAP Revista de lepidopterología. 23. 100219–100219. 1 indexed citations

Doundoulakis, Ioannis, Πέτρος Αρσένος, Στέργιος Σουλαϊδόπουλος, et al.. (2022). The Role of Genetics in Risk Stratification Strategy of Dilated Cardiomyopathy. Reviews in Cardiovascular Medicine. 23(9). 305–305. 2 indexed citations

Andrikou, Ioannis, et al.. (2022). Lipoprotein (a) and new-onset type-2 diabetes in patients with familial combined hyperlipidemia: a 9 years follow-up study. European Heart Journal. 43(Supplement_2).

Papaioannou, Theodore G., et al.. (2022). The effect of atropine used in dobutamine stress echocardiography on pupil diameter. European Journal of Ophthalmology. 32(6). 3685–3692. 3 indexed citations

Palaiodimou, Lina, Panagiotis Kokotis, Christina Zompola, et al.. (2022). Fabry Disease: Current and Novel Therapeutic Strategies. A NarrativeReview. Current Neuropharmacology. 21(3). 440–456. 21 indexed citations

Dima, Ioanna, George Andrikopoulos, Eftychia Demerouti, et al.. (2021). Treatment with a fixed dose combination for cardiovascular disease-more than a health benefit?. European Heart Journal. 42(Supplement_1). 2 indexed citations

Antonopoulos, Alexios S., Spyridon Simantiris, Marialena Trivella, et al.. (2021). Comparison of imaging vs. plasma biomarkers of vascular inflammation for cardiovascular prognostication: a meta-analysis. European Heart Journal - Cardiovascular Imaging. 22(Supplement_1). 1 indexed citations

Tsalamandris, Sotirios, Evangelos Oikonomou, Georgia Vogiatzi, et al.. (2020). X-Linked Dilated Cardiomyopathy: The Important Role of Genetic Tests and Imaging in the Early Diagnosis and Treatment. Future Cardiology. 16(6). 629–634. 1 indexed citations

10.

Vlachopoulos, C., Georgios Georgiopoulos, Dimitrios Terentes‐Printzios, et al.. (2017). The effect of TNF-a antagonists on aortic stiffness and wave reflections: a meta-analysis. Clinical Rheumatology. 37(2). 515–526. 63 indexed citations

11.

Katsi, Vasiliki, Georgios Georgiopoulos, Georgia Vogiatzi, et al.. (2017). Effects of Oral and Non-Insulin Injectable Antidiabetic Treatment in Hypertension: A Systematic Review. Current Pharmaceutical Design. 23(25). 3743–3750. 13 indexed citations

12.

Sideris, Skevos, Stefanos Archontakis, George Latsios, et al.. (2017). Biomarkers Associated with Bleeding Risk in the Setting of Atrial Fibrillation. Current Medicinal Chemistry. 26(5). 824–836. 4 indexed citations

13.

Παπαγεωργίου, Νικόλαος, Adam Ioannou, Gerasimos Siasos, et al.. (2017). Inflammatory Biomarkers in Atrial Fibrillation. Current Medicinal Chemistry. 26(5). 837–854. 24 indexed citations

14.

Kitsiou‐Tzeli, Sophia, C. Vlachopoulos, Spyridon Megremis, et al.. (2012). Sertoli cell tumor and gonadoblastoma in an untreated 29-year-old 46,XY phenotypic male with Frasier syndrome carrying a WT1 IVS9+4C>T mutation. HORMONES. 11(3). 361–367. 7 indexed citations

15.

Evangelista, Arturo, Frank A. Flachskampf, Raimund Erbel, et al.. (2010). Echocardiography in aortic diseases: EAE recommendations for clinical practice. European Journal of Echocardiography. 11(8). 645–658. 325 indexed citations

16.

Vyssoulis, Gregory P., et al.. (2010). PROSTATE SPECIFIC ANTIGEN LEVELS WITHIN NORMAL RANGE ARE ASSOCIATED WITH ARTERIAL STIFFNESS IN ESSENTIAL HYPERTENSIVE PATIENTS: PP.31.234. Journal of Hypertension. 28. e519–e519. 1 indexed citations

17.

Viigimaa, Margus, Michael Doumas, C. Vlachopoulos, et al.. (2010). Hypertension and sexual dysfunction: time to act. Journal of Hypertension. 29(2). 403–407. 48 indexed citations

18.

Vlachopoulos, C., K. Aznaouridis, Anna Dagre, et al.. (2007). Protective effect of atorvastatin on acute systemic inflammation-induced endothelial dysfunction in hypercholesterolaemic subjects. European Heart Journal. 28(17). 2102–2109. 44 indexed citations

19.

O'Rourke, M. F., Jan A. Staessen, C. Vlachopoulos, D. Duprez, & G.E. Plante. (2002). Clinical applications of arterial stiffness; definitions and reference values. American Journal of Hypertension. 15(5). 426–444. 854 indexed citations breakdown →

20.

Gatzoulis, K., et al.. (1998). Aortic mechanics during tilt-up test: insights into the mechanisms involved in neurocardiogenic syncope. Journal of the American College of Cardiology. 31. 35–35.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact